Cartesian Therapeutics, Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cartesian Therapeutics, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2023-09-30 was $0.00.
- Cartesian Therapeutics, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2023-06-30 was $0.00.
- Cartesian Therapeutics, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2023-03-31 was $0.00.
- Cartesian Therapeutics, Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2022-09-30 was $0.00.
- Cartesian Therapeutics, Inc. stock issued during period, value, restricted stock award, gross for fiscal 2022 was $0.00.
- Cartesian Therapeutics, Inc. stock issued during period, value, restricted stock award, gross for fiscal 2021 was $0.00.
- Cartesian Therapeutics, Inc. stock issued during period, value, restricted stock award, gross for fiscal 2020 was $0.00.
- Cartesian Therapeutics, Inc. stock issued during period, value, restricted stock award, gross for fiscal 2019 was $0.00.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-11-13 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $0.00 10-K · filed 2023-03-02 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-11-03 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-02 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $0.00 10-K · filed 2023-03-02 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $0.00 10-K · filed 2022-03-10 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |